US Stock MarketDetailed Quotes

Relay Therapeutics (RLAY)

Watchlist
  • 7.485
  • -0.145-1.90%
Trading Jan 16 14:57 ET
1.30BMarket Cap-4.35P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Relay Therapeutics (RLAY) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
677K
-23.26%7.68M
-60.83%10.01M
0
0
0
4,327.88%10.01M
1,749.82%25.55M
-100.40%-1K
Operating revenue
--0
--677K
-23.26%7.68M
-60.83%10.01M
--0
--0
--0
4,327.88%10.01M
1,749.82%25.55M
-100.40%-1K
Cost of revenue
Gross profit
Operating expense
-16.58%80.39M
-30.86%77.52M
-9.45%92.55M
-2.29%395.68M
-9.85%84.98M
-3.61%96.37M
3.52%112.13M
-0.20%102.2M
29.66%404.97M
12.69%94.26M
Selling and administrative expenses
-38.59%12.13M
-32.34%13.63M
-5.35%18.74M
2.19%76.59M
0.82%16.9M
6.84%19.75M
0.09%20.14M
1.12%19.8M
13.60%74.95M
2.41%16.77M
-General and administrative expense
-38.59%12.13M
-32.34%13.63M
-5.35%18.74M
2.19%76.59M
0.82%16.9M
6.84%19.75M
0.09%20.14M
1.12%19.8M
13.60%74.95M
2.41%16.77M
Research and development costs
-10.91%68.26M
-30.54%63.9M
-10.43%73.81M
-3.31%319.09M
-12.16%68.08M
-5.98%76.62M
4.30%91.99M
-0.51%82.4M
33.96%330.02M
15.19%77.5M
Operating profit
16.58%-80.39M
31.47%-76.85M
7.95%-84.87M
-1.65%-385.67M
9.85%-84.98M
-28.88%-96.37M
-3.63%-112.13M
9.77%-92.2M
-22.02%-379.42M
-13.03%-94.26M
Net non-operating interest income expense
-22.56%6.41M
-16.87%7.11M
-12.71%7.81M
11.92%34.75M
3.15%8.97M
5.47%8.27M
13.07%8.55M
28.96%8.95M
253.35%31.05M
61.95%8.7M
Non-operating interest income
-22.56%6.41M
-16.87%7.11M
-12.71%7.81M
11.92%34.75M
3.15%8.97M
5.47%8.27M
13.07%8.55M
28.96%8.95M
253.35%31.05M
61.95%8.7M
Other net income (expense)
-1,550.00%-165K
-105.57%-633K
-100.48%-9K
106.43%13.22M
-99.95%1K
-100.83%-10K
431.90%11.37M
85.70%1.86M
-45.06%6.4M
-80.34%2.07M
Special income (charges)
--0
--0
--0
105.64%13.21M
--0
--0
428.53%11.37M
82.65%1.83M
-45.00%6.42M
-80.40%2.07M
-Less：Restructuring and merger&acquisition
--0
--0
--0
-105.64%-13.21M
--0
--0
-428.53%-11.37M
-82.65%-1.83M
45.00%-6.42M
80.40%-2.07M
Other non- operating income (expenses)
-1,550.00%-165K
-31,550.00%-633K
-136.00%-9K
177.78%14K
0.00%1K
-400.00%-10K
85.71%-2K
933.33%25K
10.00%-18K
104.17%1K
Income before tax
15.84%-74.15M
23.68%-70.38M
5.31%-77.07M
1.25%-337.71M
8.97%-76M
-34.03%-88.11M
6.39%-92.21M
13.64%-81.39M
-17.72%-341.97M
-23.69%-83.5M
Income tax
Net income
15.84%-74.15M
23.68%-70.38M
5.31%-77.07M
1.25%-337.71M
8.97%-76M
-34.03%-88.11M
6.39%-92.21M
13.64%-81.39M
-17.72%-341.97M
-23.69%-83.5M
Net income continuous Operations
15.84%-74.15M
23.68%-70.38M
5.31%-77.07M
1.25%-337.71M
8.97%-76M
-34.03%-88.11M
6.39%-92.21M
13.64%-81.39M
-17.72%-341.97M
-23.69%-83.5M
Minority interest income
Net income attributable to the parent company
15.84%-74.15M
23.68%-70.38M
5.31%-77.07M
1.25%-337.71M
8.97%-76M
-34.03%-88.11M
6.39%-92.21M
13.64%-81.39M
-17.72%-341.97M
-23.69%-83.5M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
15.84%-74.15M
23.68%-70.38M
5.31%-77.07M
1.25%-337.71M
8.97%-76M
-34.03%-88.11M
6.39%-92.21M
13.64%-81.39M
-17.72%-341.97M
-23.69%-83.5M
Basic earnings per share
31.75%-0.43
40.58%-0.41
25.81%-0.46
15.41%-2.36
32.84%-0.45
-16.67%-0.63
14.81%-0.69
20.51%-0.62
-7.72%-2.79
-19.64%-0.67
Diluted earnings per share
31.75%-0.43
40.58%-0.41
25.81%-0.46
15.41%-2.36
32.84%-0.45
-16.67%-0.63
14.81%-0.69
20.51%-0.62
-7.72%-2.79
-19.64%-0.67
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 0677K-23.26%7.68M-60.83%10.01M0004,327.88%10.01M1,749.82%25.55M-100.40%-1K
Operating revenue --0--677K-23.26%7.68M-60.83%10.01M--0--0--04,327.88%10.01M1,749.82%25.55M-100.40%-1K
Cost of revenue
Gross profit
Operating expense -16.58%80.39M-30.86%77.52M-9.45%92.55M-2.29%395.68M-9.85%84.98M-3.61%96.37M3.52%112.13M-0.20%102.2M29.66%404.97M12.69%94.26M
Selling and administrative expenses -38.59%12.13M-32.34%13.63M-5.35%18.74M2.19%76.59M0.82%16.9M6.84%19.75M0.09%20.14M1.12%19.8M13.60%74.95M2.41%16.77M
-General and administrative expense -38.59%12.13M-32.34%13.63M-5.35%18.74M2.19%76.59M0.82%16.9M6.84%19.75M0.09%20.14M1.12%19.8M13.60%74.95M2.41%16.77M
Research and development costs -10.91%68.26M-30.54%63.9M-10.43%73.81M-3.31%319.09M-12.16%68.08M-5.98%76.62M4.30%91.99M-0.51%82.4M33.96%330.02M15.19%77.5M
Operating profit 16.58%-80.39M31.47%-76.85M7.95%-84.87M-1.65%-385.67M9.85%-84.98M-28.88%-96.37M-3.63%-112.13M9.77%-92.2M-22.02%-379.42M-13.03%-94.26M
Net non-operating interest income expense -22.56%6.41M-16.87%7.11M-12.71%7.81M11.92%34.75M3.15%8.97M5.47%8.27M13.07%8.55M28.96%8.95M253.35%31.05M61.95%8.7M
Non-operating interest income -22.56%6.41M-16.87%7.11M-12.71%7.81M11.92%34.75M3.15%8.97M5.47%8.27M13.07%8.55M28.96%8.95M253.35%31.05M61.95%8.7M
Other net income (expense) -1,550.00%-165K-105.57%-633K-100.48%-9K106.43%13.22M-99.95%1K-100.83%-10K431.90%11.37M85.70%1.86M-45.06%6.4M-80.34%2.07M
Special income (charges) --0--0--0105.64%13.21M--0--0428.53%11.37M82.65%1.83M-45.00%6.42M-80.40%2.07M
-Less：Restructuring and merger&acquisition --0--0--0-105.64%-13.21M--0--0-428.53%-11.37M-82.65%-1.83M45.00%-6.42M80.40%-2.07M
Other non- operating income (expenses) -1,550.00%-165K-31,550.00%-633K-136.00%-9K177.78%14K0.00%1K-400.00%-10K85.71%-2K933.33%25K10.00%-18K104.17%1K
Income before tax 15.84%-74.15M23.68%-70.38M5.31%-77.07M1.25%-337.71M8.97%-76M-34.03%-88.11M6.39%-92.21M13.64%-81.39M-17.72%-341.97M-23.69%-83.5M
Income tax
Net income 15.84%-74.15M23.68%-70.38M5.31%-77.07M1.25%-337.71M8.97%-76M-34.03%-88.11M6.39%-92.21M13.64%-81.39M-17.72%-341.97M-23.69%-83.5M
Net income continuous Operations 15.84%-74.15M23.68%-70.38M5.31%-77.07M1.25%-337.71M8.97%-76M-34.03%-88.11M6.39%-92.21M13.64%-81.39M-17.72%-341.97M-23.69%-83.5M
Minority interest income
Net income attributable to the parent company 15.84%-74.15M23.68%-70.38M5.31%-77.07M1.25%-337.71M8.97%-76M-34.03%-88.11M6.39%-92.21M13.64%-81.39M-17.72%-341.97M-23.69%-83.5M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 15.84%-74.15M23.68%-70.38M5.31%-77.07M1.25%-337.71M8.97%-76M-34.03%-88.11M6.39%-92.21M13.64%-81.39M-17.72%-341.97M-23.69%-83.5M
Basic earnings per share 31.75%-0.4340.58%-0.4125.81%-0.4615.41%-2.3632.84%-0.45-16.67%-0.6314.81%-0.6920.51%-0.62-7.72%-2.79-19.64%-0.67
Diluted earnings per share 31.75%-0.4340.58%-0.4125.81%-0.4615.41%-2.3632.84%-0.45-16.67%-0.6314.81%-0.6920.51%-0.62-7.72%-2.79-19.64%-0.67
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.41%
Sample Name
Sample Code
 +2.93%
Sample Name
Sample Code
 +2.82%
4
Block
XYZ
+1.59%
5
Broadcom
AVGO
+1.42%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +10.66%
Sample Name
Sample Code
 +10.43%
Sample Name
Sample Code
 +10.02%
4
Kingsoft Cloud
KC
+7.35%
5
United Microelectronics
UMC
+6.09%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -